Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Abbott Laboratories shares valued at $746,758 were sold by Boudreau Philip P on Aug 08 ’25. At $134.55 per share, Boudreau Philip P sold 5,550 shares. The insider’s holdings dropped to 51,003 shares worth approximately $6.7 million following the completion of this transaction.
Also, Boudreau Philip P purchased 5,550 shares, netting a total of over 746,758 in proceeds.
Before that, Blount Sally E. had sold 2,600 shares from its account. In a trade valued at $337,116, the Director traded Abbott Laboratories shares for $129.66 each. Upon closing the transaction, the insider’s holdings decreased to 2,600 shares, worth approximately $4.47 million.
As published in a research note from Jefferies on July 18, 2025, Abbott Laboratories [ABT] has been rated up from a Hold to a Buy and the price target has been revised to $145. Analysts at Leerink Partners started covering the stock with ‘”a Market perform”‘ outlook in a report released in mid June. As of October 08, 2024, Oppenheimer has initiated its “an Outperform” rating for ABT. Earlier on September 19, 2024, Piper Sandler initiated its rating. Their recommendation was “an Overweight” for ABT stock.
Analyzing ABT Stock Performance
On last trading session, Abbott Laboratories [NYSE: ABT] plunged -0.07% to $131.37. The stock’s lowest price that day was $130.14, but it reached a high of $131.635 in the same session. During the last five days, there has been a drop of approximately -0.48%. Over the course of the year, Abbott Laboratories shares have jumped approximately 16.57%. Shares of the company reached a 52-week high of $141.23 on 03/04/25 and a 52-week low of $110.86 on 01/15/25.
Support And Resistance Levels for Abbott Laboratories (ABT)
According to the 24-hour chart, there is a support level at 130.46, which, if violated, would cause prices to drop to 129.55. In the upper region, resistance lies at 131.96. The next price resistance is at 132.54. RSI (Relative Strength Index) is 51.90 on the 14-day chart, showing neutral technical sentiment.
Is Abbott Laboratories subject to short interest?
Stocks of Abbott Laboratories saw a sharp steep in short interest on 2025-08-15 dropping by -1.95 million shares to 17.11 million. Data from Yahoo Finance shows that the short interest on 2025-07-15 was 19.06 million shares. A decline of -11.38% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.18 of the overall float, the days-to-cover ratio (short ratio) decline to 2.18.
Which companies own the most shares of Abbott Laboratories (ABT)?
In terms of Abbott Laboratories share price expectations, FactSet research, analysts set an average price target of 147 in the next 12 months, up nearly 11.82% from the previous closing price of $131.46. Analysts anticipate Abbott Laboratories stock to reach 147 by 2025, with the lowest price target being 147. In spite of this, 13 analysts ranked Abbott Laboratories stock as Buy at the end of 2025.
